Summary & Overview
Shoulder, Elbow or Forearm Procedures, Except Major Joint Procedures without CC/MCC: Inpatient Reimbursement Overview
DRG 512 includes inpatient admissions for shoulder, elbow, or forearm procedures excluding major joint replacements and without Complication or Comorbidity or Major Complication or Comorbidity; it encompasses procedures such as arthroscopy, fracture fixation, and soft tissue repair. This grouping matters for inpatient reimbursement because it defines the payment bundle Medicare uses to cover typical resource use for these regional orthopedic procedures.
DRG 512 Overview
DRG 512 covers inpatient admissions for shoulder, elbow, or forearm procedures other than major joint replacements, when there is no Complication or Comorbidity and no Major Complication or Comorbidity. Typical cases include arthroscopic repairs, open fracture fixation, tendon or nerve procedures, and other regional operative interventions. This Diagnosis-Related Group matters for Medicare payment because it groups clinically similar admissions with comparable resource use to determine the bundled payment amount. Payers and hospitals monitor DRG 512 utilization and coding to align clinical documentation with reimbursement expectations.
Clinical Trials
- Acute perioperative analgesia and blood loss mitigation studies: randomized or pragmatic trials testing multimodal pain control protocols (e.g., regional nerve blocks, perioperative non-opioid analgesics) and intraoperative techniques to reduce bleeding in patients undergoing shoulder, elbow, or forearm procedures without major joint replacement. These studies enroll mostly adult inpatients scheduled for procedures such as arthroscopic rotator cuff repair, open clavicle or distal radius fixation, or surgical debridement, and measure immediate analgesic efficacy, opioid consumption, hemodynamic stability, and length of stay. Results inform perioperative care pathways that can shorten hospitalization, reduce complication-related resource use, and guide payer decisions on bundled payments and coverage for analgesic modalities.
- Comparative effectiveness trials of surgical techniques and implants for non-major joint upper extremity procedures: head-to-head studies comparing approaches (e.g., arthroscopic versus open repair, different fixation constructs for proximal humerus or distal radius fractures) that enroll heterogeneous adults including elderly osteoporotic patients and younger trauma cohorts. These trials assess functional recovery, reoperation rates, complication profiles, and short-term resource utilization up to 90 days post-op, providing direct evidence on which techniques yield better outcomes and lower downstream costs for both high-risk and routine patients. Findings are relevant to surgeons and payers by identifying procedures or devices that optimize recovery trajectories and reduce readmissions or costly revisions within the inpatient and early post-discharge window.
- Post-discharge recovery, rehabilitation, and utilization outcome studies: prospective cohort studies or randomized trials evaluating inpatient discharge planning strategies, early outpatient physical therapy delivery, tele-rehabilitation, and readmission prevention programs for patients after shoulder, elbow, or forearm procedures without major joint replacement. These studies focus on real-world populations including older adults with comorbidities and workers with return-to-work concerns, tracking functional outcome scores, adherence to rehab, emergency visits, and total 30–90 day costs. Results help hospitals and payers design discharge protocols and rehabilitation coverage policies that improve functional outcomes while limiting costly post-acute services and avoidable readmissions.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.